Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Arch. endocrinol. metab. (Online) ; 63(5): 516-523, Sept.-Oct. 2019. tab, graf
Article in English | LILACS | ID: biblio-1038509

ABSTRACT

ABSTRACT Objective To describe the prevalence, clinical characteristics and outcome of adrenal lesions in long-term follow-up of Multiple endocrine neoplasia type 1 (MEN1) patients. Subjects and methods We retrospectively studied sixteen patients from six families of individuals with MEN1. Adrenal involvement was evaluated using clinical, biochemical and imaging data. Results Adrenal lesions were identified in nine of sixteen (56.3%) patients: seven women and two men (mean age: 52.2 years). Adrenal involvement was detected at MEN1 diagnosis in more than half of the patients. Eighteen adrenal nodules were founded (median of two nodules per patient) with mean adrenal lesion diameter of 17.4 mm. Three patients had unilateral adrenal involvement. Hormonal hypersecretion (autonomous cortisol secretion) was found in two patients. None of the patients was submitted to adrenalectomy, presented an aldosterone-secreting lesion, a pheochromocytoma, an adrenal carcinoma or metastatic disease during the follow-up. A predominance of stable adrenal disease, in terms of size and hormonal secretion, was observed. Adrenal lesions were evenly distributed between the germline mutations. Conclusion Adrenal tumours are a common feature of MEN1 that can affect more than half of the patients. Most of the tumours are bilateral non-functional lesions, but hormonal secretion may occur and should be promptly identified to reduce the morbidity/mortality of the syndrome. Periodic surveillance of these patients should be performed.


Subject(s)
Humans , Male , Female , Child , Adolescent , Adult , Middle Aged , Aged , Young Adult , Adrenal Gland Neoplasms/diagnostic imaging , Multiple Endocrine Neoplasia Type 1/diagnostic imaging , Retrospective Studies , Follow-Up Studies , Adrenal Gland Neoplasms/genetics , Multiple Endocrine Neoplasia Type 1/genetics
2.
Rev. argent. radiol ; 82(3): 124-130, set. 2018. ilus
Article in Spanish | LILACS | ID: biblio-977273

ABSTRACT

Los síndromes de neoplasia endocrina múltiple (MEN), incluyen una serie de enfermedades con alteraciones genéticas que se caracterizan por la presencia de tumores que afectan a dos o más glándulas endocrinas. Son síndromes con una herencia autosómica dominante e incluyen tres patrones: MEN 1 (síndrome de Wermer), MEN 2 (que incluye MEN 2A o síndrome de Sipple y MEN 2B o síndrome de Wagenmann-Froboese) y MEN 4. Los adenomas paratiroideos y el carcinoma medular tiroideo, son los tumores más frecuentes del MEN tipo 1 y 2 respectivamente. Esos síndromes son más comunes en pacientes jóvenes, con patología de afectación bilateral, múltiple o multifocal y, sobre todo, en pacientes con antecedentes familiares. Es necesario el trabajo en equipo de endocrinólogos, cirujanos, oncólogos y radiólogos para optimizar el tratamiento de esos pacientes.


Multiple endocrine neoplasia (MEN) encompasses a serial of familial genetically disorders in wich tumors simultaneusly occur in two or more endocrine organs. MEN síndromes are autosomal-dominant disorders categorized into three main patterns: MEN 1 (Wermer syndrome), MEN 2 (includes MEN 2A o Sipple syndrome and MEN 2B o Wagenmann-Froboese syndrome) and MEN 4. Parathyroid adenomas and medullary thyroid carcinoma are the most frecuent tumors in MEN 1 and MEN 2 respectively. These entities will be suspected in younger patients, bilateral, multiple or multifocal disease and, specially, in patients with family background. Cooperation between endocrinologist, surgeons, oncologists and radiologists is pivotal for optimizing patient treatment.


Subject(s)
Humans , Multiple Endocrine Neoplasia/diagnostic imaging , Multiple Endocrine Neoplasia Type 2b/diagnostic imaging , Multiple Endocrine Neoplasia Type 2a/diagnostic imaging , Multiple Endocrine Neoplasia Type 1/diagnostic imaging , Pancreatic Neoplasms/diagnostic imaging , Parathyroid Neoplasms/diagnostic imaging , Pituitary Diseases/complications , Pituitary Diseases/diagnostic imaging , Multiple Endocrine Neoplasia/complications , Thyroid Neoplasms/diagnostic imaging , Adrenal Cortex Neoplasms/diagnostic imaging , Adrenocortical Carcinoma/diagnostic imaging , Hyperparathyroidism, Primary/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL